Variable | Lung cancer group | Control group | ||
---|---|---|---|---|
Without COPD | With COPD | COPD | Healthy individuals | |
Peripheral blood cells, mean ± SEM: |  |  |  |  |
Leukocytes, x109l | 8.57 ± 0.25*§ | 8.71 ± 0.48*§ | 5.81 ± 0.13* | 5.35 ± 0.17 |
Neutrophils, % | 65.34 ± 0.85*§ | 67.45 ± 1.43*§ | 61.77 ± 1.18* | 56.92 ± 1.65 |
Neutrophils, x109l | 5.72 ± 0.22*§ | 5.96 ± 0.39*§ | 4.35 ± 0.22* | 3.70 ± 0.25 |
Lymphocytes, % | 23.01 ± 0.79*§ | 21.11 ± 1.21*§ | 25.93 ± 0.99* | 31.64 ± 1.45 |
Lymphocytes, x109l | 1.88 ± 0.06 | 1.84 ± 0.10 | 1.78 ± 0.09 | 1.99 ± 0.09 |
Monocytes, % | 8.60 ± 0.30*§ | 8.10 ± 0.49*§ | 6.82 ± 0.29 | 6.26 ± 0.42 |
Monocytes, x109l | 0.87 ± 0.09*§ | 0.88 ± 0.17*§ | 0.46 ± 0.03 | 0.40 ± 0.03 |
Neutrophil/lymphocyte ratio, median (range) | 2.92(0.93–13.42)*§ | 3.08(1.18–8.84)* § | 2.35(1.13–4.25)§ | 1.86(1.16–3.21) |
BAL fluid cells, mean ± SEM: |  |  |  |  |
Neutrophils, % | 8.01 ± 1.37*§ | 7.94 ± 0.83*§ | 14.10 ± 2.96* | 1.29 ± 0.21 |
Neutrophils, x106/ml | 0.39 ± 0.12*§ | 0.41 ± 0.15*§ | 0.54 ± 0.22* | 0.08 ± 0.05 |
Macrophages, % | 73.59 ± 1.51§ | 72.89 ± 1.71§ | 65.50 ± 3.19* | 74.40 ± 1.77 |
Macrophages, x106/ml | 3.24 ± 0.20§ | 3.15 ± 0.30§ | 2.95 ± 0.65* | 3.21 ± 0.51 |
Lymphocytes, % | 18.21 ± 1.02 | 18.81 ± 1.48 | 19.99 ± 1.80 | 21.97 ± 1.62 |
Lymphocytes, x106/ml | 0.87 ± 0.34 | 1.03 ± 0.37 | 1.11 ± 0.53 | 0.63 ± 0.26 |
Eosinophils, % | 0.29 ± 0.04 | 0.36 ± 0.06 | 0.41 ± 0.15 | 0.34 ± 0.11 |
Eosinophils, x106/ml | 0.02 ± 0.01 | 0.01 ± 0.01 | 0.03 ± 0.01 | 0.02 ± 0.01 |